These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1096532)

  • 1. [Crug formulation and liberation of the active ingredient in of chloroquine phosphate].
    Gyarmati L; Stampf G; Morzsányi E; Soós G; Nagy E; Ablonczy E
    Acta Pharm Hung; 1975 Jul; 45(4):155-9. PubMed ID: 1096532
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
    Tang C; Godfrey T; Stawell R; Nikpour M
    Intern Med J; 2012 Sep; 42(9):968-78. PubMed ID: 22827853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histomorphology and histochemistry of changes in the dermo-epidermal area in lupus erythematosus prior to and following treatment with chloroquine phosphate].
    Bajdekoff B; Hadjioloff AI; Zvetkova E; Velev N; Mintschev I
    Dermatol Monatsschr; 1973 Sep; 159(9):880-5. PubMed ID: 4770773
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the effect of chloroquine phosphate on the glucocorticoid function of the adrenal cortex in patients with lupus erythematosus].
    Berezhnaia LA
    Vestn Dermatol Venerol; 1967 Jan; 41(1):27-8. PubMed ID: 5616446
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroquine and cytokines.
    Wallace DJ
    J Rheumatol; 1997 Oct; 24(10):2051-2. PubMed ID: 9330956
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
    Lester RS; Burnham TK; Fine G; Murray K
    Arch Dermatol; 1967 Jul; 96(1):1-10. PubMed ID: 5298279
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disseminated lupus erythematosus. The continued efficacy of hydroxychloroquine scientifically proven by default].
    Carette S
    Union Med Can; 1991; 120(5):360-4. PubMed ID: 1962386
    [No Abstract]   [Full Text] [Related]  

  • 11. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus.
    Sabbagh M
    Rev Rhum Engl Ed; 1997 Jan; 64(1):65. PubMed ID: 9051865
    [No Abstract]   [Full Text] [Related]  

  • 13. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
    Burnham TK; Neblett TR; Fine G
    Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The therapy of systemic lupus erythematosus].
    Ochsendorf FR; Runne U
    Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.